Volume 23, Number 2—February 2017
Dispatch
Persistent Infections with Diverse Co-Circulating Astroviruses in Pediatric Oncology Patients, Memphis, Tennessee, USA
Valerie Cortez, Pamela Freiden, Zhengming Gu, Elisabeth Adderson, Randall Hayden, and Stacey Schultz-Cherry
Table
Characteristics of HAstV-positive fecal samples from pediatric oncology patients, Memphis, Tennessee, USA, 2010–2011*
| Patient ID | Sample ID | Enteric co-infection† | Genotype‡ |
|---|---|---|---|
| SJ1§ | 4 | ND | HAstV2 |
| 8 |
ND |
HAstV1 |
|
| SJ2 |
9 |
ND |
VA2 |
| SJ3 |
10 |
Norovirus |
UND |
| SJ4 |
5 |
ND |
UND |
| SJ5 | 11 | ND | VA2 |
| 12 |
ND |
VA2 |
|
| SJ6 |
14 |
ND |
UND |
| SJ7 |
13 |
ND |
UND |
| SJ8 | 1 | ND | HAstV5 |
| 2 |
ND |
HAstV5 |
|
| SJ9 |
6 |
Norovirus |
HAstV1 |
| SJ10 |
3 |
ND |
HAstV1 |
| SJ11 | 7 | ND | MLB1 |
*HAstV, human astrovirus; ID, identification; ND, not detected; UND, undetermined; rRT-PCR, real-time reverse transcription PCR.
†Samples positive for either norovirus or sapovirus by rRT-PCR.
‡Genotype determined by partial open reading frame 1b and 2 sequencing.
§Patient had sequential infections with different genotypes.
Page created: January 17, 2017
Page updated: January 17, 2017
Page reviewed: January 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.